Drug Profile
Sarafloxacin
Alternative Names: A 56620Latest Information Update: 23 Jan 2013
Price :
$50
*
At a glance
- Originator Abbott Laboratories
- Class Antibacterials; Fluoroquinolones; Small molecules
- Mechanism of Action Type II DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Intestinal infections
Most Recent Events
- 28 Nov 1994 Discontinued-Preclinical for Intestinal infections in USA (Unknown route)